Douglas B. Evans, MD
Chair, Department of Surgery
Donald C. Ausman Family Foundation Chair
“We are committed to improving the care of patients – not only our patients of today but also our patients of tomorrow – through innovation, discovery and courageous approaches to medical illness.”
View Physician Profile
Douglas B. Evans, MD is the Donald C. Ausman Family Foundation Professor of Surgery and Chair of the Department of Surgery at The Medical College of Wisconsin. Prior to joining the Medical College of Wisconsin in 2009, he was the Hamill Foundation Distinguished Professor of Surgery at The University of Texas MD Anderson Cancer Center. He is board-certified in surgery, and his clinical interests include treatment of pancreatic cancer and tumors of the endocrine system (thyroid, parathyroid, adrenal and gastrointestinal neuroendocrine tumors). Dr. Evans holds appointments at Froedtert Hospital, the Clement J. Zablocki VA Medical Center and Children’s Wisconsin.
Dr. Evans has devoted his professional career to the research and treatment of pancreatic cancer and inherited endocrine syndromes. His interests include translational laboratory research in the biology of pancreatic cancer and in clinical trial development. He has completed a number of investigator-initiated clinical trials, including a National Cancer Institute Specialized Programs of Research Excellence (NIH P20 SPORE) pancreatic cancer grant. At MD Anderson, his endocrine surgery group worked extensively on the genotype-phenotype correlations in multiple endocrine neoplasia syndromes and they were the first to define the role for ultrasound in the preoperative management of patients with thyroid cancer. He was twice awarded the Outstanding Teacher Award at MD Anderson and he also received the Faculty Achievement Award in Clinical Research in 1998. Since joining MCW, Dr. Evans has grown the faculty across all clinical divisions in the department, emphasized the importance of innovation and discovery and championed the principles of inclusion and diversity. The MCW surgical residency program has led the way in supporting the careers of young women in general and subspecialty surgery. The MCW Program in Pancreatic Cancer was recently endowed by the LaBahn family and is one of very few endowed Pancreatic Cancer Research Programs in this country.
Dr. Evans is a fellow of the American College of Surgeons, and a member of the editorial boards of Surgery and The American Journal of Surgery. He is past Editor of the Pancreatic Tumors Section of the Annals of Surgical Oncology. He served on the editorial board for the seventh edition of the AJCC (American Joint Committee on Cancer) Cancer Staging Manual and chaired the committee that revised the staging system for pancreatic cancer. He has served on various national medical advisory committees and has worked extensively with patient advocacy groups including the Pancreatic Cancer Action Network (PanCAN) and the Lustgarten Foundation. In 2013 and 2014, Dr. Evans served as the Chair of the PanCAN-American Association of Cancer Research (AACR) Acceleration Network Grants Scientific Review Committee and from 2016-2018 he served on the Scientific Review Committee for the PanCAN-AACR Career Development Awards. He was appointed to the City of Hope Comprehensive Cancer Center External Advisory Board and currently serves on the Ontario Institute for Cancer Research PanCuRx Review Panel and the National Advisory Council for the Translational Genomics Research Institute (TGEN).
Dr. Evans has authored or co-authored over 400 journal articles, over 90 book chapters and has edited eight books. He has delivered countless invited and named lectureships nationally and internationally. He served as the President of the American Association of Endocrine Surgeons in 2010-2011. Dr. Evans was awarded the American College of Surgeons Traveling Fellowship to Australia and New Zealand in 1999.
Dr. Evans completed a general surgery residency at Dartmouth followed by a surgical oncology fellowship at the University of Texas MD Anderson Cancer Center. He received his medical degree from Boston University School of Medicine and his Bachelor of Science from Bates College in Lewiston, Maine. He and his wife Betsy have three adult children: Courtney (Henke), Lindsay (Black) and Bryan. His J109 sailing program named Team Time Out (after the Time Out procedure done in the operating room) is active on Lake Michigan and dedicated to pancreatic cancer awareness.
“The Word on Medicine” Radio Program highlights innovation and discovery across MCW. Podcasts of previously aired shows are available through the following streaming links: iHeartRadio, iTunes, Podbean, Stitcher.
Recent Publications from the Faculty Collaboration Database
-
(Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S.) Am J Surg. 2020 Dec 03 PMID: 33308823 SCOPUS ID: 2-s2.0-85097458297 12/15/2020
-
(Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S.) HPB (Oxford). 2020 Dec;22(12):1745-1752 PMID: 32354656 SCOPUS ID: 2-s2.0-85083782398 05/02/2020
-
Perioperative Management and Outcomes of Hyperthyroid Patients Unable to Tolerate Antithyroid Drugs.
(Hsieh LB, Yen TWF, Dream S, Patel D, Evans DB, Wang TS.) World J Surg. 2020 Nov;44(11):3770-3777 PMID: 32572525 SCOPUS ID: 2-s2.0-85086709261 06/24/2020
-
Total Neoadjuvant Therapy for Operable Pancreatic Cancer.
(Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S.) Ann Surg Oncol. 2020 Sep 30 PMID: 33000372 SCOPUS ID: 2-s2.0-85091728559 10/02/2020
-
(Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S.) Surgery. 2020 09;168(3):440-447 PMID: 32641278 SCOPUS ID: 2-s2.0-85087345792 07/10/2020
-
Commentary: Surgery for locally advanced pancreatic cancer after neoadjuvant therapy.
(Evans DB.) Surgery. 2020 Aug 28 PMID: 32868112 09/02/2020
-
Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer.
(Krepline AN, Geurts JL, George B, Kamgar M, Madhavan S, Erickson BA, Hall WA, Griffin MO, Evans DB, Tsai S, Kim RY.) Surgery. 2020 Aug 18 PMID: 32826069 SCOPUS ID: 2-s2.0-85089521842 08/23/2020
-
(Kim RY, Evans DB, Christians KK.) Hepatobiliary Surg Nutr. 2020 Aug;9(4):497-500 PMID: 32832502 PMCID: PMC7423551 08/25/2020
-
(Evans DB.) Ann Surg. 2020 Jul 09 PMID: 32657915 07/14/2020
-
(Taskin OC, Clarke CN, Erkan M, Tsai S, Evans DB, Adsay V.) J Gastrointest Oncol. 2020 Jun;11(3):548-558 PMID: 32655934 PMCID: PMC7340800 SCOPUS ID: 2-s2.0-85090285071 07/14/2020
-
Treatment sequencing for pancreatic neuroendocrine tumors: daring to challenge the status quo.
(Clarke CN, Evans DB.) J Gastrointest Oncol. 2020 Jun;11(3):545-547 PMID: 32655933 PMCID: PMC7340804 SCOPUS ID: 2-s2.0-85090280297 07/14/2020
-
(Kandimalla R, Shimura T, Mallik S, Sonohara F, Tsai S, Evans DB, Kim SC, Baba H, Kodera Y, Von Hoff D, Chen X, Goel A.) Ann Surg. 2020 May 08 PMID: 32398486 PMCID: PMC7648727 05/14/2020
-
(Rowan DJ, Hartley CP, Aldakkak M, Christians KK, Evans DB, Tsai S, Hagen CE.) Annals of Diagnostic Pathology. June 2020;46 SCOPUS ID: 2-s2.0-85081260042 06/01/2020
-
(Barnes CA, Aldakkak M, Clarke CN, Christians KK, Bucklan D, Holt M, Tolat P, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S.) Front Oncol. 2020;10:500 PMID: 32363161 PMCID: PMC7180175 SCOPUS ID: 2-s2.0-85084152103 05/05/2020